The impact of prior percutaneous coronary intervention on long-term survival after coronary artery bypass grafting

Heart Lung and Circulation

Volumn 22, Issue 11, 2013, Pages 940-945

  O'Neal, Wesley T ^a   Efird, Jimmy T ^b   Anderson, Curtis A ^b   Kindell, Linda C ^b   O'Neal, Jason B ^c   Bruce Ferguson, T ^b   Randolph Chitwood, W ^b   Kypson, Alan P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CABG; Coronary artery disease; PCI; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL TIME; TERTIARY HEALTH CARE; THERAPY EFFECT; TREATMENT PLANNING;

CABG; CORONARY ARTERY DISEASE; PCI; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; SOUTH CAROLINA; SURVIVAL RATE; TIME FACTORS;

EID: 84887825417     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.04.110     Document Type: Article

References (24)

1. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005, 46:575-581.
2. Mehta G.S., LaPar D.J., Bhamidipati C.M., Kern J.A., Kron I.L., Upchurch G.R., et al. Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting. Surgery 2012, 152:5-11.
3. Mannacio V., Di Tommaso L., De Amicis V., Lucchetti V., Pepino P., Musumeci F., et al. Previous percutaneous coronary interventions increase mortality and morbidity after coronary surgery. Ann Thorac Surg 2012, 93:1956-1962.
4. Bonaros N., Hennerbichler D., Friedrich G., Kocher A., Pachinger O., Laufer G., et al. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2009, 137:846-852.
5. Thielmann M., Leyh R., Massoudy P., Neuhauser M., Aleksic I., Kamler M., et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 2006, 114:I441-I447.
6. Hassan A., Buth K.J., Baskett R.J., Ali I.S., Maitland A., Sullivan J.A., et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 2005, 150:1026-1031.
7. Massoudy P., Thielmann M., Lehmann N., Marr A., Kleikamp G., Maleszka A., et al. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg 2009, 137:840-845.
8. Yap C.H., Yan B.P., Akowuah E., Dinh D.T., Smith J.A., Shardey G.C., et al. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery. JACC Cardiovasc Interv 2009, 2:758-764.
9. Morris P.J., Heart Disease Stroke in North Carolina. N C Med J 2012, 73:448-449.
10. Welke K.F., Ferguson T.B., Coombs L.P., Dokholyan R.S., Murray C.J., Schrader M.A., et al. Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg 2004, 77:1137-1139.
11. Lash T.L., Silliman R.A. A comparison of the National Death Index and Social Security Administration databases to ascertain vital status. Epidemiology 2001, 12:259-261.
12. Morales D.L., McClellan A.J., Jacobs J.P. Empowering a database with national long-term data about mortality: the use of national death registries. Cardiol Young 2008, 18:188-195.
13. Grambsch P., Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994, 81:515-526.
14. Alfonso F., Hernandez C., Perez-Vizcayno M.J., Hernandez R., Fernandez-Ortiz A., Escaned J., et al. Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis. J Am Coll Cardiol 2000, 36:1549-1556.
15. Goldman S., Zadina K., Moritz T., Ovitt T., Sethi G., Copeland J.G., et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004, 44:2149-2156.
16. Muhlestein J.B. Endothelial dysfunction associated with drug-eluting stents what, where, when, and how. J Am Coll Cardiol 2008, 51:2139-2140.
17. Epstein A.J., Polsky D., Yang F., Yang L., Groeneveld P.W. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011, 305:1769-1776.
18. Ko W., Tranbaugh R., Marmur J.D., Supino P.G., Borer J.S. Myocardial revascularization in New York State: variations in the PCI-to-CABG ratio and their implications. J Am Heart Assoc 2012, 1:e001446.
19. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315-1323.
20. Mauri L., O'Malley A.J., Popma J.J., Moses J.W., Leon M.B., Holmes D.R., et al. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2005, 95:1140-1145.
21. Buller C.E., Rankin J.M., Carere R.G., Buszman P.E., Pfisterer M.E., Dzavik V., et al. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. Am Heart J 2009, 158:408-415.
22. Heitjan D.F. Incomplete data: what you don't know might hurt you. Cancer Epidemiol Biomarkers Prev 2011, 20:1567-1570.
23. Schafer J.L., Graham J.W. Missing data: our view of the state of the art. Psychol Methods 2002, 7:147-177.
24. Efird J.T., Lea S., Toland A., Phillips C.J. Informational odds ratio: a useful measure of epidemiologic association in environment exposure studies. Environ Health Insights 2012, 6:17-25.